dynamin inhibitory peptide Search Results


hy p1083  (MedChemExpress)
92
MedChemExpress hy p1083
Hy P1083, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynamin+inhibitory+peptide/Dynamin+inhibitory+peptide/pm39264811-827-205-203
Average 92 stars, based on 1 article reviews
hy p1083 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
dynamin inhibitory peptide, myristoylated  (MuseChem Chemicals)
N/A
DynaMin inhibitory peptide, myristoylated (Cat No.: P000104), is a cell-permeable peptide inhibitor designed to block dynamin-dependent endocytosis. The myristoyl modification enhances membrane association and cellular uptake, enabling effective intracellular activity. By interfering with dynamin GTPase
   Buy from Supplier
dynamin inhibitory peptide  (MedChemExpress)
94
MedChemExpress dynamin inhibitory peptide
A , Timeline of the experiments. B , Representative confocal maximum projection images of dendritic sections of mature hippocampal neurons expressing scrambled (shNT) or KCC2a-specific (shKCC2a) shRNA, treated with a <t>dynamin</t> <t>inhibitory</t> peptide (DiP, 50 µM) 40 minutes before and during live Flag immunostaining. Scale: 5 µm. C , Summary boxplot showing the ratio of plasmalemmal (surf.) to the overall (total) KCC2b-Flag immunofluorescence intensity, normalized to control shNT condition. shNT control, n = 37; shNT +DiP, n = 39; shKCC2a control, n = 42; shKCC2a +DiP, n = 41 cells, from 4 independent cultures. Mann-Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. *p < 0.05. D , Representative confocal maximum projection images of dendritic sections of hippocampal neurons expressing scrambled (shNT) or KCC2a-specific shRNA. Two hours before immunostaining with a panKCC2 antibody, neurons were treated with either a proteasome blocker (MG132, 2.5 µM), an inhibitor of the ubiquitin-activating enzyme (PYR-41, 50 µM), or untreated (control). Scale: 5 µm. E , Summary boxplot showing the intensity of endogenous KCC2 immunofluorescence in the different conditions, normalized to shNT control. shNT control, n = 44; shNT +MG132, n = 38; shNT +PYR41, n = 43; shKCC2a control, n = 43; shKCC2a +MG132, n = 40; shKCC2a +PYR41, n = 44 cells, from 4 independent cultures. Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. **p < 0.01.
Dynamin Inhibitory Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynamin+inhibitory+peptide/DynaMin+inhibitory+peptide%2C+myristoylated/bio_rxiv__64898__2026__01__25__701648-189-12-19
Average 94 stars, based on 1 article reviews
dynamin inhibitory peptide - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
dynamin inhibitory control peptide, sequence prapnsrqpv  (GenScript corporation)
90
GenScript corporation dynamin inhibitory control peptide, sequence prapnsrqpv
A , Timeline of the experiments. B , Representative confocal maximum projection images of dendritic sections of mature hippocampal neurons expressing scrambled (shNT) or KCC2a-specific (shKCC2a) shRNA, treated with a <t>dynamin</t> <t>inhibitory</t> peptide (DiP, 50 µM) 40 minutes before and during live Flag immunostaining. Scale: 5 µm. C , Summary boxplot showing the ratio of plasmalemmal (surf.) to the overall (total) KCC2b-Flag immunofluorescence intensity, normalized to control shNT condition. shNT control, n = 37; shNT +DiP, n = 39; shKCC2a control, n = 42; shKCC2a +DiP, n = 41 cells, from 4 independent cultures. Mann-Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. *p < 0.05. D , Representative confocal maximum projection images of dendritic sections of hippocampal neurons expressing scrambled (shNT) or KCC2a-specific shRNA. Two hours before immunostaining with a panKCC2 antibody, neurons were treated with either a proteasome blocker (MG132, 2.5 µM), an inhibitor of the ubiquitin-activating enzyme (PYR-41, 50 µM), or untreated (control). Scale: 5 µm. E , Summary boxplot showing the intensity of endogenous KCC2 immunofluorescence in the different conditions, normalized to shNT control. shNT control, n = 44; shNT +MG132, n = 38; shNT +PYR41, n = 43; shKCC2a control, n = 43; shKCC2a +MG132, n = 40; shKCC2a +PYR41, n = 44 cells, from 4 independent cultures. Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. **p < 0.01.
Dynamin Inhibitory Control Peptide, Sequence Prapnsrqpv, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynamin+inhibitory+peptide/dynamin+inhibitory+control+peptide++sequence+prapnsrqpv/pm37730989-500-21-25
Average 90 stars, based on 1 article reviews
dynamin inhibitory control peptide, sequence prapnsrqpv - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dynamin inhibitory peptide tat-qvpsrpnrap  (ChinaPeptides)
90
ChinaPeptides dynamin inhibitory peptide tat-qvpsrpnrap
A , Timeline of the experiments. B , Representative confocal maximum projection images of dendritic sections of mature hippocampal neurons expressing scrambled (shNT) or KCC2a-specific (shKCC2a) shRNA, treated with a <t>dynamin</t> <t>inhibitory</t> peptide (DiP, 50 µM) 40 minutes before and during live Flag immunostaining. Scale: 5 µm. C , Summary boxplot showing the ratio of plasmalemmal (surf.) to the overall (total) KCC2b-Flag immunofluorescence intensity, normalized to control shNT condition. shNT control, n = 37; shNT +DiP, n = 39; shKCC2a control, n = 42; shKCC2a +DiP, n = 41 cells, from 4 independent cultures. Mann-Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. *p < 0.05. D , Representative confocal maximum projection images of dendritic sections of hippocampal neurons expressing scrambled (shNT) or KCC2a-specific shRNA. Two hours before immunostaining with a panKCC2 antibody, neurons were treated with either a proteasome blocker (MG132, 2.5 µM), an inhibitor of the ubiquitin-activating enzyme (PYR-41, 50 µM), or untreated (control). Scale: 5 µm. E , Summary boxplot showing the intensity of endogenous KCC2 immunofluorescence in the different conditions, normalized to shNT control. shNT control, n = 44; shNT +MG132, n = 38; shNT +PYR41, n = 43; shKCC2a control, n = 43; shKCC2a +MG132, n = 40; shKCC2a +PYR41, n = 44 cells, from 4 independent cultures. Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. **p < 0.01.
Dynamin Inhibitory Peptide Tat Qvpsrpnrap, supplied by ChinaPeptides, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynamin+inhibitory+peptide/dynamin+inhibitory+peptide+tat+qvpsrpnrap/pmc04223322-94-28-37
Average 90 stars, based on 1 article reviews
dynamin inhibitory peptide tat-qvpsrpnrap - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dynamin inhibitory peptide, myristoylated  (BOC Sciences)
N/A
An inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis.
   Buy from Supplier
dynamin inhibitory peptide acetate  (TargetMol)
N/A
   Buy from Supplier
dynamin inhibitory peptide tfa  (TargetMol)
N/A
   Buy from Supplier
dynamin inhibitory peptide, myristoylated  (TargetMol)
N/A
   Buy from Supplier
dynamin inhibitory peptide, myristoylated  (Biosynth Carbosynth)
N/A
   Buy from Supplier
dynamin inhibitory peptide, myristoylated acetate  (TargetMol)
N/A
   Buy from Supplier
dynamin inhibitory peptide tfa  (Aladdin Scientific Corporation)
N/A
   Buy from Supplier

Image Search Results


A , Timeline of the experiments. B , Representative confocal maximum projection images of dendritic sections of mature hippocampal neurons expressing scrambled (shNT) or KCC2a-specific (shKCC2a) shRNA, treated with a dynamin inhibitory peptide (DiP, 50 µM) 40 minutes before and during live Flag immunostaining. Scale: 5 µm. C , Summary boxplot showing the ratio of plasmalemmal (surf.) to the overall (total) KCC2b-Flag immunofluorescence intensity, normalized to control shNT condition. shNT control, n = 37; shNT +DiP, n = 39; shKCC2a control, n = 42; shKCC2a +DiP, n = 41 cells, from 4 independent cultures. Mann-Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. *p < 0.05. D , Representative confocal maximum projection images of dendritic sections of hippocampal neurons expressing scrambled (shNT) or KCC2a-specific shRNA. Two hours before immunostaining with a panKCC2 antibody, neurons were treated with either a proteasome blocker (MG132, 2.5 µM), an inhibitor of the ubiquitin-activating enzyme (PYR-41, 50 µM), or untreated (control). Scale: 5 µm. E , Summary boxplot showing the intensity of endogenous KCC2 immunofluorescence in the different conditions, normalized to shNT control. shNT control, n = 44; shNT +MG132, n = 38; shNT +PYR41, n = 43; shKCC2a control, n = 43; shKCC2a +MG132, n = 40; shKCC2a +PYR41, n = 44 cells, from 4 independent cultures. Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. **p < 0.01.

Journal: bioRxiv

Article Title: Differential isoform-specific control of KCC2 function in developing cortical neurons

doi: 10.64898/2026.01.25.701648

Figure Lengend Snippet: A , Timeline of the experiments. B , Representative confocal maximum projection images of dendritic sections of mature hippocampal neurons expressing scrambled (shNT) or KCC2a-specific (shKCC2a) shRNA, treated with a dynamin inhibitory peptide (DiP, 50 µM) 40 minutes before and during live Flag immunostaining. Scale: 5 µm. C , Summary boxplot showing the ratio of plasmalemmal (surf.) to the overall (total) KCC2b-Flag immunofluorescence intensity, normalized to control shNT condition. shNT control, n = 37; shNT +DiP, n = 39; shKCC2a control, n = 42; shKCC2a +DiP, n = 41 cells, from 4 independent cultures. Mann-Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. *p < 0.05. D , Representative confocal maximum projection images of dendritic sections of hippocampal neurons expressing scrambled (shNT) or KCC2a-specific shRNA. Two hours before immunostaining with a panKCC2 antibody, neurons were treated with either a proteasome blocker (MG132, 2.5 µM), an inhibitor of the ubiquitin-activating enzyme (PYR-41, 50 µM), or untreated (control). Scale: 5 µm. E , Summary boxplot showing the intensity of endogenous KCC2 immunofluorescence in the different conditions, normalized to shNT control. shNT control, n = 44; shNT +MG132, n = 38; shNT +PYR41, n = 43; shKCC2a control, n = 43; shKCC2a +MG132, n = 40; shKCC2a +PYR41, n = 44 cells, from 4 independent cultures. Whitney rank-sum tests, p-value corrected for multiple comparisons using the Holm-Šídák method. **p < 0.01.

Article Snippet: Clathrin-mediated endocytosis was inhibited by incubating neurons for 40 min with the Dynamin Inhibitory Peptide, myristoylated (DiP) (50 μM, MedChemExpress) in complete culture medium at 37°C.

Techniques: Expressing, shRNA, Immunostaining, Immunofluorescence, Control, MANN-WHITNEY, Ubiquitin Proteomics